All In MedTech

Device Trial Radar · NCT03713268

Intraoperative OCT Guidance of Intraocular Surgery II

Intraoperative OCT Guidance of Intraocular Surger

Last checked: Nov 20, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

262

Planned (sponsor's estimate)

Start

Sep 30, 2018

Primary completion

Dec 31, 2026

Study completion May 31, 2027

Sponsor

Lead sponsor
Duke UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Eye Institute (NEI)
First posted
Oct 19, 2018

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 4 weeks
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The overall five-year goals of the project are to develop novel technology to provide actionable new information through provision of live volumetric imaging during surgery, improving surgical practice and outcomes. The investigators believe this technology will enable novel ophthalmic and other microsurgeries not possible due to current limitations in surgical visualization.

Conditions

  • Macular Holes
  • Epiretinal Membrane
  • Diabetic Retinopathy
  • Retinal Detachment
  • Retinal Disease
  • Preretinal Fibrosis
  • Cataract
  • Ocular Tumor
  • Strabismus
  • Healthy

Interventions

  • Microscope integrated optical coherence tomographyDevice

    This is translational study in which subjects will either be imaged with a microscope integrated optical coherence tomography (MIOCT) system or they will use MIOCT during surgical procedures. OCT systems are optical imaging technology that allow non-contact imaging of the microanatomy of the retina, cornea, optic nerve head and retinal blood vessels. The MIOCT has been integrated into the surgical microscope used in retinal and anterior segment surgeries so it does not touch the eye. Unlike visible light from many examination devices, the infrared OCT beam is barely visible to the human eye as it sweeps across the retina. Thus the patient is not disturbed by the light.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Retinal and/or corneal microscope integrated optical coherence tomography image captureTime frame: Year 1
  2. Quality of retinal and/or corneal microscope integrated optical coherence tomography image captureTime frame: Year 1
  3. Retinal vascular flow on optical coherence tomography angiography (OCTA) versus fluorescein angiographyTime frame: Year 1

3 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Duke University Eye Center

    Durham, North Carolina · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.